2018) The role of thiamine dependent enzymes in obesity and obesity related chronic disease states: a systematic review.
The WHO 2016 report indicates that worldwide obesity is rising, with 23 over 600 million people in the obese range (BMI>30). The recommended daily 24 calorie intake for adults is 2000 kcal and 2500 kcal for women and men 25 respectively. The average American consumes 3770 kcal/ day and the average 26 person in the UK consumes 3400 kcal/ day. With such increased caloric intake, 27
there is an increased load on metabolic pathways, in particular glucose 28 metabolism. Such metabolism requires micronutrients as enzyme co-factors. The 29 recommended daily allowance (RDA) for thiamine is 1.3mg/day and 0.5mg 30 thiamine is required to process 1000 kilocalories (kcal). Therefore, despite the 31 appearance of being overfed, there is now increasing evidence that the obese 32 population may nutritionally depleted of essential micronutrients. Thiamine 33 deficiency has been reported to be in the region of 16 -47% among patients 34 undergoing bariatric surgery for obesity. Thiamine, in turn, requires magnesium 35 to be in its active form, thiamine diphosphate (TDP). TDP also requires 36 magnesium to achieve activation of TDP dependent enzymes, including 37 transketolase (TK), pyruvate dehydrogenase (PDH) and alpha-keto glutaric acid 38 dehydrogenase (AKGDH), during metabolism of glucose. Thiamine and 39 magnesium therefore play a critical role in glucose metabolism and their 40 deficiency may result in the accumulation of anaerobic metabolites including 41 lactate due to a mismatch between caloric burden and function of thiamine 42 dependent enzymes. It may therefore be postulated that thiamine and 43 magnesium deficiency are under-recognized in obesity and may be important in 44 the progress of obesity and obesity related chronic disease states. The aim of the 45 present systematic review was to examine the role of thiamine dependent 46 Introduction 66
In 2008 it was estimated that 1·46 billion adults worldwide were 67 overweight and 502 million people were estimated to be in the obese range (1). 68
The WHO 2016 report indicates that these figures have significantly increased, 69 estimating more than 1.9 billion adults are overweight (BMI>25), of which over 70 600 million of these are obese (BMI>30) (2). Alarmingly, childhood obesity levels 71
have risen in tandem with adult obesity. WHO statistics reveal that 41 million 72 children under the age of 5 were overweight or obese in 2014 (2). 73
Increasing obesity is primarily due to increased consumption of calories 74
(3, 4). The recommended daily calorie intake is 2000 kcal and 2500 kcal for adult 75 women and men respectively (4). The average American consumes 3770 kcal/ 76 day and the average person in the UK consumes 3400 kcal/ day (1). These 77
figures are steadily rising due to the ready availability of 'high sugar, low 78 nutrient' foods, that characterize the North American and Western European diet 79 (5). Chronic calorie excess is now endemic in Western society, with a reported 80 35 -40% North Americans having BMI's in the obese range (BMI>30) (4). Indeed, 81
obesity has now overtaken smoking to become the number one cause of 82 preventable death in some of the Western nations (6) (7) (8) . 83
The burden of obesity worldwide now poses a significant risk to 84 population health and some experts warn that the obesity pandemic threatens to 85 reverse the gains achieved in risk reduction for cardiovascular and cancer deaths 86 over the past three decades (1, 4, 9) . The caloric burden on individuals in 87
Western societies has increased as a consequence of changing diet. This has 88 imposed a sugar rich nutritional intake on a metabolism evolved in a sugar poor 89 evolutionary environment (10-13). Total health-care costs attributable to 90 obesity and overweight are projected to double every decade to account for 16-91 18% of total US health-care expenditure by 2030 (1). 92
Despite the appearance of being overfed, there is now increasing evidence 93 that this population is nutritionally depleted of essential micronutrients and 94 vitamins (14-16). In 2012 the National Research Council reported that >80% 95
Americans consumed a diet, which was deficient for vitamins and minerals (15, 96 17). The NHANES 3 study reported that multi-nutrient deficiencies were more 97 prevalent in those with a BMI in the obese range than in the normal population 98 (18-21). In the present review we will examine the role of thiamine, an essential 99 component in the metabolism of glucose, in patients with obesity. 
Search strategy and methodology 111
This review set out to examine, in a systematic manner, studies that 112 report association between obesity, thiamine and /or magnesium deficiency, and 113
proposes the novel concepts that a combined deficiency of thiamine and 114 magnesium may result in loss of responsiveness to insulin by the pyruvate 115 dehydrogenase enzyme complex, and that this may serve as the metabolic 116 fulcrum underpinning pseudohypoxic disease processes. 117 A PubMed literature search was performed in accordance with the 118 PRISMA statement. The search focused on obesity and bariatric surgery in 119 relation to thiamine or magnesium deficiency. Search keywords included: 120 "bariatric surgery" OR "obesity" OR "non-insulin dependent diabetes" OR "type 2 121 diabetes" OR "metabolic syndrome" AND "thiamine" OR "thiamine deficiency", 122 AND "magnesium" OR "magnesium deficiency". Inclusion criteria for each article 123 were: an experimental or observational measurement of thiamine and or 124 magnesium in relation to obesity or bariatric surgery at any age in human 125 studies, case reports and animal studies were excluded. Supporting evidence was 134 provided by in vitro and ex vivo cellular studies of adipocytes in eligible human 135 studies. There were no language or date restrictions. A copy of articles that met 136 Under normal physiological and nutritional conditions, the average adult 148 human has approximately a 3-week reserve of thiamine in the liver. It is 149 postulated that these reserves become rapidly depleted in disease, surgery or 150 times of sustained physiological stress (28-33). 151
The measurement of thiamine in red blood cells is known to reflect 152 nutritional status, and is not perturbed by the systemic inflammatory response 153 (34-36). Therefore, it is of interest that thiamine deficiency has been reported to 154 be in the region of 16 -29% among patients undergoing bariatric surgery for 155 obesity (37-39), and this deficiency was reported to be even higher (31 -47%) 156 among some ethnic groups (15, 38). These findings are endorsed by a cross-157 sectional study of thiamine consumption in a population of 1,100 Mexican-158 American children, generated from NHANES data, which reported that thiamine 159 consumption may be inversely associated with obesity in that group (40). 160
Thiamine deficiency has also been reported to be present in up to 75% of 161 both type 1 and type 2 diabetics (41), and urinary excretion of thiamine has been 162 reported to be 24 times higher in Type 1 diabetes and 16 times higher in type 2 163 diabetes as compared to normal controls (41). Hence, thiamine deficiency has 164 been proposed as a mediator of insulin resistance and loss of oxidative resilience 165 in diabetes (42). 166
A pilot cross-over prospective randomized controlled trail (PRCT) (n= 12) 167
reported that thiamine supplementation (100mg taken three times per day for 6 168 weeks) resulted in significant decrease in 2-h plasma glucose relative to baseline 169 (8.78 +/-2.20 vs. 9.89 +/-2.50 mmol/l, p = 0.004) (43). It has also been reported 170 that thiamine supplementation may exert a nephro-protective effect in NIDDM 171 patients with evidence of early stage diabetic nephropathy and pilot studies have 172 yielded encouraging results (44, 45). 173
Given that the recommended daily allowance for thiamine is 1.3mg/day, 174 and that the average daily intake of thiamine from food for American adults is 175 1.87mg and 1.39mg in men and women respectively (46), and from the 176 combination of food and supplements is 4.90 in both men and women (47), it is 177 perhaps surprising that there are reported deficiencies in the obese. However, 178 the current recommended daily allowance for thiamine is based on studies 179 undertaken in the 1930's on healthy volunteers (48). At this time daily calorie 180 intakes were far lower than today. Nevertheless, from this work it may be 181 assumed that 0.5mg thiamine is required to process 1000kcal (kcal) (18, 23, 49). 182
On the basis of a 4000 kcal/day intake, it might be expected that an appropriate 183 RDA would be 2.0 mg /day. However, this would assume a linear relationship 184 between calories consumed and thiamine requirement. Red cell TDP measurement from whole blood is recognized as a reliable 211 measure of thiamine status, which some regard as equivalent or superior to 212 ETKA measurement (53, 54). Red cell TDP assay may have an advantage over the 213 ETKA assay for detecting tissue thiamine accumulation, however ETKA has the 214 benefit of being a functional marker of thiamine status (55). Red cell TDP is more 215 commonly measuremed, as ETKA is a more time consuming assay to perform 216 (56). In particular, processing of blood samples for ETKA assay is time and 217 temperature dependent, as processing or storage delay renders the sample 218 prone to variable kinetics (57). Talwar and colleagues have reported that direct 219 measurement of whole-blood TDP mass is most accurately expressed when 220 placed in the context of haemoglobin mass (expressed in units: nanogram of TDP 221 per gram of haemoglobin i.e. ng/g Hb) (54) as this corrects for unavoidable 222 pipetting related volume sampling error. 223
Red cell TDP measurement was used in two of the bariatric surgery 224 studies described above (37, 39). It is interesting to note however that the 225 normal ranges and deficiency thresholds listed for each study vary significantly 226 between institutions, and that certain patients deemed to be deficient in one 227 study would not have met the criteria for biochemical deficiency in another (see 228 appendix 3) (37, 38, 58). Indeed, one of the studies provided no specific values of 229 whole blood thiamine concentrations, however this study does correlate clinical 230 criteria of symptoms related to thiamine deficiency with biochemically proven 231 deficiency measured in whole blood (i.e. red cell thiamine diphosphate) (38). 232
Overall, there is some evidence of an association between thiamine 233 deficiency and obesity, however given the scale of the problem there is a relative 234 paucity of robust data available describing thiamine status in obese patients. Tricarboxylic Acid (TCA) cycle (64). This may be considered to be the optimal 251 metabolism of glucose i.e. 'a clean burn'. 252
Thiamine in the form of thiamine diphosphate (TDP) (also known as 253 thiamine pyrophosphate) is required as a co-factor for pyruvate dehydrogenase 254 (PDH) and alpha ketoglutaric acid dehydrogenase (KGDH), both key enzymes for 255 the TCA cycle. Therefore, thiamine deficiency compromises these enzymes and 256 results in an altered metabolism of glucose. to an Intensive Care Unit (ICU) is consistently associated with a higher 90-day 294 mortality than a lactate concentration ≤2 mmol/L (43% vs. 22%) (79). 295
Furthermore, patients who continue to manifest hyperlactatemia (>2 mmol/L) at 296 ≥72 hours post admission to ICU are reported to have more than double the 90-297 day mortality when compared with those patients whose lactate concentration 298 has resolved to ≤2.0 mmol/L at the same time point (52% vs. 24%) (79). Chronic Similarly, defects of the genes that code for elements of the PDHC result in 336 inborn errors of metabolism e.g. Leigh syndrome, which are also characterized 337 by impaired glucose metabolism and increased lactic acid production (77, 88). 338
Due to the reliance of the nervous system upon carbohydrate metabolism, these 339 syndromes may manifest profound neurological symptoms, such as 340 developmental delay and ataxia (84, 88). 341
These conditions vary in severity and responsiveness to thiamine therapy 342 according to the degree of penetrance of the genetic defect (77, 86). While these 343 genetic variants provide valuable insight into thiamine dependent metabolic 344 processes, the overall incidence of these conditions is very rare. For example, 345 It is of interest that a recent NHANES study would suggest that two thirds 358 of North Americans may be magnesium deficient (20, 47, 93). The RDA for 359 magnesium is 320mg and 420mg for women and men respectively (47). 360
Dietary intake of magnesium may be subnormal by 65 -220mg /day depending 361 on geographic region (11, 93). Chronic ingestion of excessive amounts of sugar in 362 the context of a micronutrient poor diet may, given the requirement for TDP and 363 magnesium, results in altered metabolism (i.e. a dirty burn) (94). For example, 364 obesity is also reported to be associated with magnesium deficiency (95-99). 365
Intracellular magnesium also plays a key role in regulating insulin action, 366
insulin-mediated-glucose-uptake and vascular tone (95, 98, 100, 101). Several 367 epidemiologic studies have shown that adults and children consuming a western 368 type diet are consuming 30 -50% of the RDA for magnesium (47, 93, 102) . This 369 deficiency appears to be predominantly subclinical and therefore not routinely 370 investigated (11, 94, 103, 104) . 371
Furthermore, the measurement of magnesium in the blood is 372 problematical since it is recognized to be perturbed by the systemic 373 inflammatory response (105), and measurable serum magnesium accounts for 374 only 0.15% of total body magnesium. As a result, serum concentrations are likely 375 to poorly reflect intracellular magnesium reserves (11, 103, 106). Finally, the 376 accepted normal range was originally described among a population who may 377 have been deficient (11, 106-109). 378
It is therefore of interest that recent meta-analyses and cohort studies 379 have pointed to an inverse relationship between magnesium consumption and 380 the incidence of NIDDM / metabolic syndrome (95, 110-121) and that a recent 381 prospective randomized controlled trial has demonstrated enhanced insulin 382 sensitivity in a population of 128 obese patients with confirmed 383 hypomagnesemia, chronic renal impairment and impaired glucose tolerance, in 384 response to magnesium supplementation (365 mg per day for three months 385 duration) (122). A similar study in a smaller sample size (n=72) of obese 386 patients with metabolic syndrome, confirmed reduced baseline intracellular 387 (monocyte) magnesium concentrations in 36% of obese patients but did not 388 report any improvement in markers of insulin resistance in response to 389 magnesium supplementation (400 mg per day for three months duration), 390 however potential compliance issues and a small study sample render these 391 Overall, when thiamine deficiency is considered with magnesium, it is 404 likely that the deficiency of one or both may affect the other and compromise 405 glucose metabolism in the obese patient. 406 407
Compromised PDH activity and lactate production in obesity 408
Consistent with the above, it has been recognized for decades that lactate 409 concentrations are chronically elevated in obese diabetic patients (126) (127) (128) (129) . 410
Adipocytes are known to produce lactate and it is accepted that raised lactate 411 precedes the onset of insulin resistance in obese patients (128, 130 Compromised PDH activity results in a 'dirty burn' and the accumulation of 417 lactate (73). Furthermore, lactate load is recognized to be proportionate to the 418 mass of adipocytes (133), and the rate of lactate production has also been 419 reported to be associated with the age of the adipocyte. Hence lactate production 420 may be proportionate to the extent and duration of the obesity state (128). 421
Chronically elevated lactate therefore heralds the onset of insulin resistance and 422 NIDDM (134). 423
Clearly, in the context of the present review, this may reflect progressive 424 exhaustion of intracellular thiamine and / or magnesium reserves due to a 425 sustained high caloric burden. This simple hypothesis may be readily tested in 426 the obese population by examination of the relationship between thiamine, 427 magnesium and lactate. 428
The implications of the above observations are several and profound, as 429 subclinical thiamine and / or magnesium deficiency may render the individual 430 more vulnerable to insulin resistance and oxidative stress in the acute or chronic 431 disease state (135, 136) . 432
With reference to chronic disease, it is recognized that an elevated BMI in 433 the obese range is an established risk factor for diseases such as type 2 diabetes 434 (T2DM), cardiovascular diseases, and many cancers (95, 137). Indeed, dietary 435 intake of thiamine and magnesium and their circulating concentrations have 436 been associated with lower risk of these conditions (95, 97, 114, (138) (139) (140) (141) (142) . For 437 example, Wu et al conducted a meta-analysis which indicates that circulating 438 magnesium levels are inversely associated with incidence of CHD, hypertension, 439 and T2DM (114). Despite numerous reviews highlighting a potential role for 440 magnesium in T2DM (95, 114, 138) , no definitive study has been conducted to 441 clarify the therapeutic potential of this widely available nutritional supplement 442 in the treatment of T2DM and associated complications. Similarly, despite 443 identification of widespread thiamine deficiency among patients with T2DM and 444 promising pilot study data in relation to treatment of the metabolic 445 complications of T2DM with thiamine (44, 142), the protective effect of thiamine 446 supplementation remains unproven in a prospective randomised controlled trial 447
setting. 448
Furthermore, the specific biological mechanism mediating the interface 449 between obesity, thiamine, magnesium and these conditions is not yet clear and 450 no study has examined the combined effect of thiamine and magnesium in this 451 spectrum of chronic disease conditions. 452
453

Conclusion 454
In summary, there is evidence that obesity may be associated with 455 thiamine deficiency. This may be due to a mismatch between caloric burden and 456 function of thiamine dependent enzymes. Thiamine, in turn, requires magnesium 457 to be in its active form TDP. TDP also requires magnesium to achieve activation 
